This study initially included 78 eyes of 78 patients with CON, of which 15 were excluded because of optic disc edema at the time of OCT examination (n = 4), poor image quality that did not allow clear delineation of each retinal layer (n = 5), and being diagnosed with simultaneous glaucoma (n = 6). Of the remaining 63 patients, 36 were diagnosed with pituitary adenoma, 11 with craniopharyngioma, and 16 with suprasellar meningioma. Seventy-two age- and refraction-matched control eyes and 68 age-, refraction-, and VF-MD-matched GON eyes were recruited from the database of IGPS and LCES.
Table 1 lists the characteristics of the study participants. Baseline IOP was lower in CON than in the control group (
P = 0.012). Patients with CON had worse best-corrected visual acuity than the other two groups (all
P < 0.001). No significant differences were found between groups in terms of age, sex, and refractive errors. Visual field MD did not differ between the CON and GON groups.
Table 2 compares the mRNFL, mGCL, and cpRNFL thicknesses between the study groups. Relative to eyes in the healthy control group, the mRNFL was thinner in the CON group in six subfields [superior (OS, IS), nasal (IN, ON), and inferior (II, OI)] and in the GON group in only two subfields (OT and OI); and the mGCL was thinner in the CON group in all nine subfields and thinner in the GON group in only four subfields [temporal (IT, OT) and inferior (II, OI)]. The macular analysis did not show either mRNFL or mGCL thinning in the nasal and superior subfields in the GON group. The cpRNFL was significantly thinned globally and in the TS, T, TI, and N sectors in the CON group, and globally and in the TS, TI, NI, and N sectors in the GON group. The T-sector cpRNFL was not involved in the GON group. The patterns of thinning of the mRNFL, mGCL, and cpRNFL in CON and GON compared to the control group are also shown in
Figure 1. There were significant differences between the CON and GON groups in the mRNFL thickness in the C, IS, IN, OT, OI, and ON subfields; in the mGCL thickness in the C, IS, IN, OT, and ON subfields; and in the cpRNFL thickness in the T, TI, NI, and NS sectors.
Figure 2 compares the percentage thicknesses of the mRNFL, mGCL, and cpRNFL in the CON and GON groups for data normalized relative to the average thickness in the control group.
The diagnostic performance of each parameter for CON and GON, as well as the usefulness in discriminating between CON and GON, was assessed using the AUC (
Table 3). The AUCs for diagnosing CON were largest for the IS-subfield mGCL thickness (0.878), IN-subfields, mGCL thickness (0.854), and T-sector cpRNFL thickness (0.835). The AUCs for diagnosing GON were largest for the TI-sector cpRNFL thickness (0.926), OT-subfield mGCL thickness (0.840), and OI-subfield mRNFL thickness (0.832). The best parameter for discriminating between CON and GON was the IS-subfield mGCL thickness (AUC = 0.837), followed by the IN-subfield mGCL thickness (AUC = 0.819) and IN-sector cpRNFL thickness (AUC = 0.788) (
Table 3).
Figures 3,
4, and
5 illustrate the characteristic patterns of macular and peripapillary damage in CON and GON with early, moderate, and advanced VF damage, respectively. In eyes with early to moderate VF damage, the pattern of damage was clearly distinguishable between CON and GON in all mRNFL and mGCL thickness maps and the cpRNFL diagram as follows: selective loss of the mGCL in the nasal hemiretina and cpRNFL thinning in the T and N sectors, with relative sparing of arcuate mRNFL and cpRNFL fibers in CON (
Figs. 3,
4); versus obvious thinning of arcuate areas of the mRNFL, mGCL, and cpRNFL with relative sparing of the inner-subfield macular thicknesses in GON. However, the difference in the mRNFL and cpRNFL profiles between CON and GON was less definite in the advanced stage, while the pattern of mGCL thinning remained distinct (
Fig. 5).
Figure 6 shows the usefulness of SD-OCT in distinguishing CON when optic disc and VF findings are unremarkable. Specifically, the mGCL thickness map clearly displayed RGC damage of neurologic origin.